Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacterial Translocation in Spondyloarthritis (TEARE-BIO)
NCT05244109Unknown
- Sponsor
- CHU de Besançon
- Start
- Feb 2022
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Randomised, open-label trial in axial spondyloarthritis (axSpA) (3 arms), sponsored by CHU de Besançon. Primary endpoint: Serum lipopolysaccharide concentration at 3 months. Status: unknown.
02
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT05244109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05244109.